Skip to content
Screener

Annexon ANNX Operating Cash Flow

Operating Cash Flow at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$813M-29.0%
Omeros logo
OmerosOMER
-$14.51M+59.5%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$13.42M-11.6%
Jade Biosciences logo
Jade BiosciencesJBIO
-$24.08M-28.4%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-$28.86M-4.4%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$38.22M+33.7%

Other financials

Income statement

See full
Operating income-$46.1M+19.8%
Net income-$44.1M+18.8%
EPS (diluted)-$0.23+37.8%

Balance sheet

See full
Cash & equivalents$175.2M+80.4%
Total debt$25.4M-10.2%
Total equity$204.5M-16.1%
Total assets$262.9M-13.2%

Cash flow

See full
CapEx--100%
Free cash flow-$46.8M+6.6%

Valuation

See full
Market cap$886.39M+244%
Enterprise value$736.61M+381%

Returns & leverage

See full
Return on equity-87.6%+42.3pp
Debt / equity0.1×0.0×
Current ratio6.4×-1.6×

Where this comes from

Reported directly by Annexon in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The source filing: Annexon’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211931
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Accounts payable2,151(31)
Accrued and other current liabilities(9,399)2,926
Operating lease liabilities(767)(664)
Net cash used in operating activities(46,796)(50,055)
Investing activities:
Purchases of property and equipment(74)
Purchases of available-for-sale securities(5,944)(61,806)
Proceeds from maturities of available-for-sale securities33,000159,500

Cover / Front Matter

FAQ

What is Annexon's operating cash flow?
Annexon (ANNX) reported operating cash flow of -$46.8M in Q1 2026.
How has Annexon's operating cash flow changed year-over-year?
Annexon's operating cash flow increased by 6.5% year-over-year, from -$50.06M to -$46.8M.
What is the long-term trend for Annexon's operating cash flow?
Over 4 years (2021 to 2025), Annexon's operating cash flow has grown at a 15.1% compound annual growth rate (CAGR), from -$106.11M to -$186.36M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Ask your AI about Annexon's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude